glp-1 receptor agonists and sglt2 inhibitors Combining in Type 2 Diabetes Mellitus: A Scoping Review and Expert Insights for Clinical Practice Utilizing the Nominal Group Technique | Diabetes Therapy Blood pressure lowering effects of
Description
Following the predefined inclusion and exclusion criteria, 36 studies were included in this systematic review and underwent qualitative analysis

COA included

Obesity is a complex disease, excessive fat accumulation caused by genetic, environmental and other factors, that has seen the most rapid growth in terms of ...

However, heterogeneous experimental designs and limited translational data necessitate further standardized and in vivo research to define clinical applications.

Tirzepatide, characterized by its ability to selectively bind and activate receptors for the intestinal hormones GIP and GLP-1, has been tested in numerous clinical studies and is already currently authorized in several countries for the treatment of type 2 diabetes and obesity
